Pfizer Inc. and Biohaven Pharmaceutical announced that Pfizer will acquire Biohaven for $11.6 billion in cash after years of collaborative drug development, improving access to medicine used to treat...
Sandoz, a Novartis division, recently acquired a UK-based medical and drug delivery device company, Coalesce Product Development Limited.
Through the terms of the agreement, Sandoz...
Thermo Fisher Scientific recently completed the $1.85 billion acquisition of PeproTech to increase its capabilities in the high growth cell and gene therapy market.
PeproTech is a privately held...
Pfizer recently entered into a $6.7 billion proposed pharma acquisition deal with Arena Pharmaceuticals to develop therapies for chronic disease management.
Arena Pharmaceutical’s...
Novo Nordisk recently entered into a pharma acquisition deal with Dicerna Pharmaceuticals to increase its pipeline of RNAi therapies and technology platforms.
Dicerna develops RNAi-based...
Merck recently entered into an $11.5 billion pharma acquisition deal with biotechnology company Acceleron Pharma to strengthen its cardiovascular pipeline.
Acceleron focuses on transforming the...
AstraZeneca’s Alexion will fully acquire the remaining equity in Caelum Biosciences for the company’s first-in-class fibril-reactive monoclonal antibody (mAb) to treat rare disease light...
Roche recently signed a definitive share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group to enhance its molecular diagnostic solutions portfolio.
The...
Sanofi recently entered into a $1.9 billion pharma acquisition deal with Kadmon Holdings to strengthen the growth of its transplant business.
Under the terms of the agreement, Sanofi will continue to...
Pfizer recently entered into a $2.26-billion pharma acquisition deal with clinical-stage immuno-oncology company, Trillium, to strengthen its next-generation, investigational immuno-therapeutics...
Bayer recently entered into a pharma acquisition deal with Vividion Therapeutics to unlock high value, traditionally undruggable targets with precision therapeutics.
Vividion will leverage its...
Sanofi and Translate Bio recently entered into a $3.2 billion pharma acquisition deal to accelerate the development of mRNA vaccines and therapeutics.
Under the terms of the acquisition,...
BioNTech recently entered into an agreement with Kite, a Gilead subsidiary, to acquire its solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility to...
Eli Lilly and Company recently entered into a pharma acquisition deal with biotechnology company, Protomer Technologies, to advance treatment for type 1 diabetes (TD1).
Protomer...
Gene therapy company uniQure recently entered into a pharma acquisition deal with Corlieve Therapeutics to lead its program for temporal lobe epilepsy.
The program, known as AMT-260, leverages...
Pfizer recently announced that it has acquired Amplyx Pharmaceuticals to expand its anti-infective therapies pipeline.
Amplyx’s lead compound, Fosmanogepix, is a novel investigational...
Hologic, a global leader in women’s health, recently signed a $795 million definitive agreement to acquire Mobidiag Oy, a commercial stage developer of innovative molecular...
The Federal Trade Commission (FTC) recently launched a working group to update its approach to analyzing the effects of pharmaceutical mergers and acquisitions.
The joint project will adopt...
Amgen has acquired Five Prime Therapeutics in a $1.9 billion pharma acquisition deal to advance its immuno-oncology and targeted cancer therapies portfolio.
The acquisition adds Five...
Thermo Fisher Scientific recently announced that it entered into a $450 million definitive agreement to acquire San Diego-based Mesa Biotech, Inc. and boost the availability of reliable molecular...
